Effect of Ginkgo Leaf Extract and Dipyridamole Injection on left ventricular ejection fraction and serum B-type natriuretic peptide in patients with chronic heart failure
-
摘要: 目的 探讨银杏达莫注射液对慢性心力衰竭患者左室射血分数(LVEF)及血清B型利钠肽(BNP)水平的影响。 方法 将80例慢性心力衰竭患者随机分为观察组和对照组,每组40例。对照组给予常规治疗,观察组在对照组基础上联合银杏达莫注射液治疗。治疗2周后,比较2组治疗总有效率、不良反应发生率、LVEF和BNP水平。 结果 治疗后,观察组总有效率为95.00%, 高于对照组的77.50%, 差异有统计学意义(P<0.05); 2组不良反应发生率比较,差异无统计学意义(P>0.05); 2组LVEF均升高,且观察组高于对照组; 2组BNP水平均下降,且观察组低于对照组,差异有统计学意义(P<0.05)。 结论 银杏达莫注射液治疗慢性心力衰竭效果显著,可有效改善患者心功能,降低血清BNP水平,安全性良好。Abstract: Objective To explore the effect of Ginkgo Leaf Extract and Dipyridamole Injection on left ventricular ejection fraction(LVEF)and serum B-type natriuretic peptide(BNP)levels in patients with chronic heart failure. Methods A total of 80 patients with chronic heart failure were randomly divided into observation group and control group, with 40 cases in each group. The control group was given routine treatment, while the observation group was treated with Ginkgo Leaf Extract and Dipyridamole Injection on the basis of the control group. After 2 weeks of treatment, the total effective rate, incidence of adverse reactions, LVEF and BNP levels of the two groups were compared. Results After treatment, the total effective rate of the observation group was 95.00%, which was significantly higher than 77.50% of the control group(P<0.05); there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05); LVEF was significantly increased in both groups, and it was significantly higher in the observation group than that in the control group(P<0.05); BNP levels in both groups were significantly decreased, and it was significantly lower in the observation group than that in the control group(P<0.05). Conclusion Ginkgo Leaf Extract and Dipyridamole Injection can effectively improve the heart function of patients with chronic heart failure, reduce serum BNP levels, and it is a safe and effective treatment.
-
-
谢进, 胡沛, 许臣洪, 等. 参附注射液联合新活素对老年慢性心力衰竭患者心功能及血清BNP、MMP-9、CypA水平的影响[J]. 现代生物医学进展, 2018, 18(7): 1306-1309. BESNIER F, LABRUNÉE M, RICHARD L, et al. Short-term effects of a 3-week interval training program on heart rate variability in chronic heart failure. A randomised controlled trial[J]. Ann Phys Rehabil Med, 2019, 62(5): 321-328.
陈有志. 苦碟子注射液联合芪苈强心胶囊对老年慢性心力衰竭病人血清BNP、NF-κB水平的影响[J]. 中西医结合心脑血管病杂志, 2019, 17(10): 1504-1507. 邱军杰, 雷肖蠢, 王西辉. 银杏达莫注射液联合氯吡格雷治疗急性冠脉综合征的临床研究[J]. 现代药物与临床, 2017, 32(10): 1859-1863. 陈灏珠. 实用内科学[M]. 北京: 人民卫生出版社, 2017. 中华人民共和国卫生部. 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 1993: 57- 60. PACKER M, GRAYBURN P A. Contrasting effects of pharmacological, procedural, and surgical interventions on proportionate and disproportionate functional mitral regurgitation in chronic heart failure[J]. Circulation, 2019, 140(9): 779-789.
罗磊. 参麦注射液对慢性心力衰竭病人BNP水平与心功能的影响[J]. 中西医结合心脑血管病杂志, 2018, 16(24): 3643-3645. SCIATTI E, DALLAPELLEGRINA L, METRA M, et al. New drugs for the treatment of chronic heart failure with a reduced ejection fraction: What the future may hold[J]. J Cardiovasc Med(Hagerstown), 2019, 20(10): 650-659.
崔敏玲, 祝建芳, 张敏. 银杏达莫注射液对慢性心力衰竭血栓前状态标志物的影响[J]. 血栓与止血学, 2019, 25(3): 398-400. 李娟, 尹胜, 李定祥. 参附养心汤对老年阳虚水泛型慢性心力衰竭患者心功能及血清IL-6、TNF-α、hs-CRP水平的影响[J]. 湖南中医药大学学报, 2017, 37(12): 1386-1390. WOO V, CONNELLY K, LIN P, et al. The role of sodium glucose cotransporter-2(SGLT-2)inhibitors in heart failure and chronic kidney disease in type 2 diabetes[J]. Curr Med Res Opin, 2019, 35(7): 1283-1295.
李斌, 康爱玲, 沈洁. 芪苈强心胶囊治疗对老年慢性心力衰竭患者脑钠肽水平及预后的影响[J]. 山西医药杂志, 2018, 47(22): 2642-2644. JANUZZI J L, AHMAD T, MULDER H, et al. Natriuretic peptide response and outcomes in chronic heart failure with reduced ejection fraction[J]. J Am Coll Cardiol, 2019, 74(9): 1205-1217.
杨峰, 王莉. 银杏达莫对高血压合并心力衰竭患者血液流变学的影响[J]. 现代中西医结合杂志, 2017, 26(2): 194-196. ALEM M M. Endothelial dysfunction in chronic heart failure: assessment, findings, significance, and potential therapeutic targets[J]. Int J Mol Sci, 2019, 20(13): 3198-3214.
-
期刊类型引用(4)
1. 王杰,王霞,李静,李燕燕,花淑婷,孙亚坤. 联合检测血清PLA2R、IgG4对特发性膜性肾病诊断的临床价值分析. 医药论坛杂志. 2024(23): 2532-2536 . 百度学术
2. 王晓,张铁征,王春宁,李敏. CysC、SCr、BUN在肾病患者外周血中的检测意义. 标记免疫分析与临床. 2022(07): 1170-1173 . 百度学术
3. 罗熙,远方. 从“瘀”论治膜性肾病. 中医药临床杂志. 2022(12): 2238-2241 . 百度学术
4. 温玉,刘嘉伟,邱友春,李莉华,杨雪. 血清PLA2R、IgG4检测对特发性膜性肾病的诊断中的临床价值分析. 临床和实验医学杂志. 2021(16): 1712-1716 . 百度学术
其他类型引用(1)
计量
- 文章访问数: 414
- HTML全文浏览量: 121
- PDF下载量: 15
- 被引次数: 5